Biopsy Devices | Market Insights | Europe (Supplemental) | 2017
The European market for biopsy devices will be driven primarily by wider implementation of national cancer screening programs, an increase in reimbursement coverage for biopsy procedures, increasing adoption of premium-priced devices, and favorable demographics. In addition, the ongoing shift from reusable to disposable devices, coupled with improved patient perception surrounding biopsy procedures and screening tests, will have a significant impact on the market; overall, these factors will result in market growth through 2025.
This Medtech 360 Report provides high-level market metrics for biopsy devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.
